Neurological Biomarkers Market Size, Share & Trends Report

Neurological Biomarkers Market (2025 - 2030) Size, Share & Trends Analysis Report By Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism), By Type, By End Use, By Region, And Segment Forecasts

Market Segmentation

Neurological Biomarkers Type Outlook (Revenue, USD Million, 2018 - 2030)
- Genomic
- Proteomic
- Metabolomic
- Imaging
- Others

Neurological Biomarkers Application Outlook (Revenue, USD Million, 2018 - 2030)
- Alzheimer's Disease
- Parkinson's Disease
- Multiple Sclerosis
- Autism Spectrum Disorder
- Others
Neurological Biomarkers End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Research Organizations
- Pharma & Biotech Companies
- Clinical Diagnostics
Neurological Biomarkers Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Neurological Biomarkers Market, By Type
    - Genomic
    - Proteomic
    - Metabolomic
    - Imaging
    - Others
  - North America Neurological Biomarkers Market, By Application
    - Alzheimer's Disease
    - Parkinson's Disease
    - Multiple Sclerosis
    - Autism Spectrum Disorder
    - Others
  - North America Neurological Biomarkers Market, By End Use
    - Research Organizations
    - Pharma & Biotech Companies
    - Clinical Diagnostics
  - U.S.
    - U.S. Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - U.S. Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - U.S. Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - Canada
    - Canada Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Canada Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Canada Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - Mexico
    - Mexico Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Mexico Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Mexico Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
- Europe
  - Europe Neurological Biomarkers Market, By Type
    - Genomic
    - Proteomic
    - Metabolomic
    - Imaging
    - Others
  - Europe Neurological Biomarkers Market, By Application
    - Alzheimer's Disease
    - Parkinson's Disease
    - Multiple Sclerosis
    - Autism Spectrum Disorder
    - Others
  - Europe Neurological Biomarkers Market, By End Use
    - Research Organizations
    - Pharma & Biotech Companies
    - Clinical Diagnostics
  - UK
    - UK Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - UK Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - UK Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - Germany
    - Germany Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Germany Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Germany Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - France
    - France Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - France Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - France Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - Spain
    - Spain Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Spain Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Spain Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - Italy
    - Italy Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Italy Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Italy Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - Denmark
    - Denmark Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Denmark Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Denmark Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - Sweden
    - Sweden Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Sweden Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Sweden Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - Norway
    - Norway Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Norway Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Norway Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
- Asia Pacific
  - Asia Pacific Neurological Biomarkers Market, By Type
    - Genomic
    - Proteomic
    - Metabolomic
    - Imaging
    - Others
  - Asia Pacific Neurological Biomarkers Market, By Application
    - Alzheimer's Disease
    - Parkinson's Disease
    - Multiple Sclerosis
    - Autism Spectrum Disorder
    - Others
  - Asia Pacific Neurological Biomarkers Market, By End Use
    - Research Organizations
    - Pharma & Biotech Companies
    - Clinical Diagnostics
  - Japan
    - Japan Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Japan Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Japan Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - China
    - China Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - China Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - China Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - India
    - India Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - India Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - India Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - South Korea
    - South Neurological Biomarkers Korea Type Outlook
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - South Korea Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - South Korea Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - Australia
    - Australia Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Australia Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Australia Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - Thailand
    - Thailand Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Thailand Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Thailand Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
- Latin America
  - Latin America Neurological Biomarkers Market, By Type
    - Genomic
    - Proteomic
    - Metabolomic
    - Imaging
    - Others
  - Latin America Neurological Biomarkers Market, By Application
    - Alzheimer's Disease
    - Parkinson's Disease
    - Multiple Sclerosis
    - Autism Spectrum Disorder
    - Others
  - Latin America Neurological Biomarkers Market, By End Use
    - Research Organizations
    - Pharma & Biotech Companies
    - Clinical Diagnostics
  - Brazil
    - Brazil Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Brazil Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Brazil Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - Argentina
    - Argentina Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Argentina Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Argentina Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
- Middle East & Africa
  - Middle East & Africa Neurological Biomarkers Market, By Type
    - Genomic
    - Proteomic
    - Metabolomic
    - Imaging
    - Others
  - Middle East & Africa Neurological Biomarkers Market, By Application
    - Alzheimer's Disease
    - Parkinson's Disease
    - Multiple Sclerosis
    - Autism Spectrum Disorder
    - Others
  - Middle East & Africa Neurological Biomarkers Market, By End Use
    - Research Organizations
    - Pharma & Biotech Companies
    - Clinical Diagnostics
  - South Africa
    - South Africa Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - South Africa Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - South Africa Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - Saudi Arabia
    - Saudi Arabia Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Saudi Arabia Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Saudi Arabia Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - UAE
    - UAE Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - UAE Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - UAE Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics
  - Kuwait
    - Kuwait Neurological Biomarkers Market, By Type
      - Genomic
      - Proteomic
      - Metabolomic
      - Imaging
      - Others
    - Kuwait Neurological Biomarkers Market, By Application
      - Alzheimer's Disease
      - Parkinson's Disease
      - Multiple Sclerosis
      - Autism Spectrum Disorder
      - Others
    - Kuwait Neurological Biomarkers Market, By End Use
      - Research Organizations
      - Pharma & Biotech Companies
      - Clinical Diagnostics

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments